Zobrazeno 1 - 10
of 321
pro vyhledávání: ''
Autor:
Mark-David Levin, Paula F. Ypma, Sonja Zweegman, Monique C. Minnema, Pieter Sonneveld, Esther G. M. de Waal, Eduardus F. M. Posthuma, Mirian Brink, Kaz Groen, Niels W.C.J. van de Donk, Ellen van der Spek, Avinash G Dinmohamed, Annemiek Broijl
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 11, Pp 1-7 (2021)
Blood Cancer Journal, 11(11):178. Nature Publishing Group
Blood Cancer Journal
Brink, M, Groen, K, Sonneveld, P, Minnema, M C, Broijl, A, Dinmohamed, A G, van der Spek, E, Levin, M D, Ypma, P F, de Waal, E, Posthuma, E F M W, Zweegman, S & van de Donk, N W C J 2021, ' Decrease in early mortality for newly diagnosed multiple myeloma patients in the Netherlands : a population-based study ', Blood cancer journal, vol. 11, no. 11, 178 . https://doi.org/10.1038/s41408-021-00571-8
Blood cancer journal, 11(11):178. Nature Publishing Group
Blood Cancer Journal, 11(11):178. Nature Publishing Group
Blood Cancer Journal
Brink, M, Groen, K, Sonneveld, P, Minnema, M C, Broijl, A, Dinmohamed, A G, van der Spek, E, Levin, M D, Ypma, P F, de Waal, E, Posthuma, E F M W, Zweegman, S & van de Donk, N W C J 2021, ' Decrease in early mortality for newly diagnosed multiple myeloma patients in the Netherlands : a population-based study ', Blood cancer journal, vol. 11, no. 11, 178 . https://doi.org/10.1038/s41408-021-00571-8
Blood cancer journal, 11(11):178. Nature Publishing Group
Identification of risk factors for early mortality (EM) in multiple myeloma (MM) patients may contribute to different therapeutic approaches in patients at risk for EM. This population-based study aimed to assess trends in EM and risk factors for EM
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 6, Iss 1, Pp 1-7 (2021)
Signal Transduction and Targeted Therapy
Signal Transduction and Targeted Therapy
This study (ORIENT-4) aimed to assess the efficacy and safety of sintilimab, a humanized anti-PD-1 antibody, in patients with relapsed/refractory extranodal NK/T cell lymphoma (r/r ENKTL). ORIENT-4 is a multicenter, single-arm, phase 2 clinical trial
Autor:
Jacalyn Rosenblatt, Diane Warren, Kelly Masone, Dena Grayson, Sascha A. Tuchman, Kathleen Colson, Paul G. Richardson, Jacob P. Laubach, Robert A. Redd, Constantine S. Mitsiades
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 2, Pp 1-8 (2021)
Blood Cancer Journal
Blood Cancer Journal
Additional therapeutic options are needed for relapsed and refractory multiple myeloma (RRMM). We present data from a phase 1b, open-label, dose-escalation study (NCT01965353) of 20 patients with RRMM (median age: 63 years [range: 50–77]) and a med
Refinement of prognosis and the effect of azacitidine in intermediate-risk myelodysplastic syndromes
Autor:
Vasileios Papadopoulos, Charalambos Pontikoglou, Panagiotis Zikos, Argiris Symeonidis, Eleftheria Hatzimichael, Panayiotis Panayiotidis, Maria Papaioannou, Konstantinos Liapis, Maria Ximeri, Dimitris Τsokanas, Anna Vardi, Nora-Athina Viniou, Theodoros P. Vassilakopoulos, Flora N. Kontopidou, Stamatis Karakatsanis, Eleni Bouronikou, Nikolaos Harchalakis, Ioannis Adamopoulos, Sotirios G. Papageorgiou, Menelaos Papoutselis, Aekaterini Megalakaki, George Vrachiolias, Ioannis Kotsianidis, Alexandra Kourakli, Vassiliki Pappa, Athanasios Galanopoulos, Maria Dimou, Panagiotis T. Diamantopoulos
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 2, Pp 1-7 (2021)
Blood Cancer Journal
Blood Cancer Journal
Autor:
Yan Gao, Jun Cai, Yi Xia, Qingqing Cai, Shuyun Ma, Yuchen Zhang, Lirong Li, Xiaopeng Tian, Hang Yang, Panpan Liu, Yajun Li, Xuanye Zhang, Hui Zhou, Huiqiang Huang
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 5, Iss 1, Pp 1-9 (2020)
Signal Transduction and Targeted Therapy
Signal Transduction and Targeted Therapy
Advanced natural killer/T cell lymphoma (NKTL) has demonstrated poor prognosis with currently available therapies. Here, we report the efficacy of anti-programmed death 1 (PD-1) antibody with the P-GEMOX (pegaspargase, gemcitabine, and oxaliplatin) r
Autor:
Shengkai Li, Chun-Quan Ou, Heyang Sun, Bowen Lan, Li Li, Haiyang Dai, Zhiyan Zhang, Kangyin Chen, Wei Ye, Runhui Tang, Xinmiao Ye
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
Scientific Reports
Scientific reports, 10:19649
Scientific Reports
Scientific reports, 10:19649
We examined characteristics of chest CT during different time periods for patients with coronavirus disease 2019 (COVID-19) pneumonia in Huizhou, China. This study included 56 COVID-19 patients having abnormal CT acquired between January 22 and March
Publikováno v:
Translational Psychiatry, Vol 10, Iss 1, Pp 1-12 (2020)
Translational Psychiatry, 10 (1)
Translational Psychiatry
Translational Psychiatry, 10 (1)
Translational Psychiatry
Intranasal administration of the neuropeptide oxytocin (IN-OT) is increasingly considered as a potential treatment for targeting the core symptoms of autism spectrum disorder (ASD), but the effects of continual use on neural substrates are fairly une
Autor:
Bethania Fernandes, Massimo Roncalli, Corrado Tinterri, Alberto Testori, Giovanna Masci, Wolfgang Gatzemeier, Elisa Agostinetto, Agnese Losurdo, Rita De Sanctis, Valentina Errico, Armando Santoro, Rosalba Torrisi
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Scientific Reports
Scientific Reports
Triple negative breast cancer (TNBC), usually presenting with a very aggressive phenotype, is a heterogeneous entity. We aim to discuss new biomarkers, suitable for prognostic and predictive purposes. We retrospectively collected clinical variables a
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-17 (2020)
Scientific Reports
Scientific Reports
Heart disease is a fatal human disease, rapidly increases globally in both developed and undeveloped countries and consequently, causes death. Normally, in this disease, the heart fails to supply a sufficient amount of blood to other parts of the bod
Autor:
Kuai Yu, Zhengming Chen, Canqing Yu, Wending Li, Yu Guo, Liming Li, Frank B. Hu, Tangchun Wu, Zheng Bian, Ling Yang, Yiping Chen, Jun Lv, Gaokun Qiu
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Scientific Reports
Scientific Reports
Exhaled carbon monoxide (COex) level has been proposed as a noninvasive and easily-obtainable cardiovascular risk marker, however, with limited prospective evidence, and its association with stroke risk has been rarely explored. Measurements of COex